---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000021"
form_type: "8-K"
ticker: "CDIO"
cik: "0001870144"
company_name: "Cardio Diagnostics Holdings, Inc."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T04:14:21.415204+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cardio Diagnostics terminates $11.2M convertible debenture agreement with Yorkville

## Summary
- Mutual termination of Securities Purchase Agreement effective Jan 4, 2024; no fees or penalties due.
- First $5.0M debenture (issued for $4.5M) had been fully repaid before termination.
- Second $6.2M debenture ($5.58M purchase price) was never issued; conditions remained unsatisfied.
- No outstanding borrowings, advance notices, or shares to be issued under the agreement at termination.

## SEC filing metadata
- accession: 0001079973-24-000021
- form_type: 8-K
- ticker: CDIO
- cik: 0001870144
- company_name: Cardio Diagnostics Holdings, Inc.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870144/000107997324000021/0001079973-24-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870144/000107997324000021/cdio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000021
- JSON: https://secwatch.observer/filing/0001079973-24-000021.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000021.txt

## Key facts
- Material Agreements
  Cardio Diagnostics Holdings, Inc. terminated Securities Purchase Agreement with YA II PN, Ltd. valued at up to $11.2 million (effective 2024-01-04).
  - Action: termination
  - Agreement: equity purchase
  - Counterparty: YA II PN, Ltd.
  - Value: up to $11.2 million
  - Effective: 2024-01-04
  source text: On January 4, 2024, Cardio Diagnostics Holdings, Inc. (the “Company”) and YA II PN, Ltd. (“Yorkville”), an affiliate of Yorkville Advisors Global, LP, terminated the Securities Purchase Agreement dated as of March 8, 2023, as amended (the “Securities Purchase Agreement”) by the mutual consent of the parties, effective as of January 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1870144/000107997324000021/0001079973-24-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.